Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

WATERTOWN, Mass., Aug. 11, 2023 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...
-August 11, 2023 at 07:01 am- MarketScreener

Related Keywords

Charles Chuck Baum ,Alexandra Santos ,Adam Levy ,Peter Blume Jensen ,Chuck Baum ,Drug Administration ,Acrivon Therapeutics Inc ,Exchange Commission ,Fast Track ,Acrivon Predictive Precision Proteomics ,Private Securities Litigation Reform Act ,Media Contacts ,Consolidated Statements ,Months Ended ,